Evaluation of Empiric Antibacterial Treatment and Subsequent De-escalation for Febrile Neutropenia
Background: Febrile neutropenia (FN) is the most common complication of chemotherapy-induced neutropenia that affects over 80% of patients with hematologic malignancies. National guidance and randomized controlled trial data demonstrate empiric antimicrobial therapy (EAT) can be discontinued after 7...
Saved in:
Main Authors: | Eunice Kim (Author), Christopher McCoy (Author), Ryan Chapin (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
by: Doaa Naeem, et al.
Published: (2018) -
Optimizing Empiric Vancomycin Use in Febrile Neutropenia Patients
by: Nicole Tadros, et al.
Published: (2021) -
Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia
by: Nagua Giurici, et al.
Published: (2011) -
NEUTROPENIA FEBRIL EN PEDIATRIA Febrile Neutropenia in Pedriatrics
by: Pio Lopez, et al.
Published: (2008) -
Antimicrobial de-escalation in patients with high-risk febrile neutropenia: Attitudes and practices of adult hospital care providers
by: Chelsea A. Gorsline, et al.
Published: (2021)